Anika Therapeutics(ANIK) - 2025 Q4 - Annual Results

Exhibit 10.2 EMPLOYMENT AGREEMENT This Employment Agreement ("Agreement") shall be effective as of February 1, 2026 between Anika Therapeutics, Inc., a Delaware corporation (the "Company"), and Steve Griffin (the "Executive"). WHEREAS, the Executive is currently serving as Chief Financial Officer and Chief Operating Officer of the Company; WHEREAS, the Company and the Executive are currently party to an Executive Retention Agreement, dated December 12, 2024 (the "Prior Agreement"); and WHEREAS, the Company ...